Gamma rhythms (30-80 Hz) are modulated during cognition, and impaired gamma rhythms have been associated with Alzheimer's disease (AD).
But do they play a causal role? New evidence shows that non-invasive sensory stimulation using 40 Hz rhythm power and synchrony in AD mouse models reduces AD-like pathology and enhances cognitive function.
Gamma rhythms (30-80 Hz) are modulated during cognition, and impaired gamma rhythms have been associated with Alzheimer's disease (AD).
But do they play a causal role? New evidence shows that non-invasive sensory stimulation using 40 Hz rhythm power and synchrony in AD mouse models reduces AD-like pathology and enhances cognitive function.
Research is ongoing to understand the mechanisms underlying the beneficial effects of 40 Hz stimulation and to translate this intervention for human patients.
Attendees will learn about:
Speaker Information:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks, All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy